Suvretta Capital Management reported a 49.9% stake in Benitec Biopharma BNTC · 15,623,659 sh · amendment

Trade details

Type: 5% stake report
Report: 13D · amendment
Stake: 49.9%
Last report: No earlier report
Shares held: 15,623,659 sh
Class: Common Stock, par value $0.0001
Stock: Benitec Biopharma BNTC
Holder: Suvretta Capital Management
Event date: 25/03/26
Filed: 25/03/28

49.9% stake

Benitec Biopharma trades, last 26 weeks

What else happened in Benitec Biopharma around then

Filed or reported within 30 days of the trade day · 25/02/24~25/04/25

Suvretta Capital Management's other 5% stake reports

Montanova Capital
5% stakeVeradermics
5% stake
Veradermics
MANE
8.8% stake
3,718,970 sh
8.8% stake
Filed 08/21
Montanova Capital
5% stakeAbeona Therapeutics
5% stake
Abeona Therapeutics
ABEO
0.9% stake
500,000 sh
0.9% stake
Filed 08/14
Montanova Capital
5% stakeMonte Rosa Therapeutics
5% stake
Monte Rosa Therapeutics
GLUE
4.2% stake
3,549,539 sh
4.2% stake
Filed 08/14
Montanova Capital
5% stakeFulcrum Therapeutics
5% stake
Fulcrum Therapeutics
FULC
5.5% stake
3,680,921 sh
5.5% stake
Filed 08/14
Montanova Capital
5% stakeInflaRx
5% stake
InflaRx
IFRX
15.6% stake
22,933,910 sh
15.6% stake
Filed 08/14

Suvretta Capital Management reported a 49.9% stake in Benitec Biopharma BNTC · 15,623,659 sh · amendment | Whalegun